secwatch / observer

8-K filed August 16, 2024, 7:59 PM ET ticker CDT CIK 0001896212

other material confidence high sentiment negative materiality 0.85

Conduit Pharmaceuticals receives Nasdaq delisting notices; discloses 31% of shares pledged without company knowledge

CDT Equity Inc.

Nasdaq notified Conduit on Aug 15, 2024 for non-compliance: MVPHS <$15M and MVLS <$50M; 180-day cure period until Feb 11, 2025.
Company disclosed that a director's subsidiary pledged a substantial amount of shares without company knowledge.
Approximately 30M shares (31% of outstanding) are subject to a third-party pledge with a significant stockholder.
Board formed a Special Committee to review pledge transactions and a Trading Review Committee to investigate trading patterns.

item 3.01 item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-032854
form_type: 8-K
ticker: CDT
cik: 0001896212
company_name: CDT Equity Inc.
filed_at: 2024-08-16T23:59:59+00:00
discovered_at: 2026-05-14T18:03:15.142711+00:00
generated_at: 2026-05-31T08:53:45.210587+00:00
sec_items: ["3.01", "8.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-032854
json_url: https://secwatch.observer/filing/0001493152-24-032854.json
markdown_url: https://secwatch.observer/filing/0001493152-24-032854.md
text_url: https://secwatch.observer/filing/0001493152-24-032854.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315224032854/0001493152-24-032854-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315224032854/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment

Charlotte's Web Holdings, Inc. June 1, 2026, 5:13 PM ET other_material Items 5.02, 5.07, 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

IMRX

Immuneering reports 17.3-month median OS in Phase 2a pancreatic trial of atebimetinib

Immuneering Corp June 1, 2026, 4:51 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

PRAX

Praxis Precision Medicines: Phase 2/3 vormatrigine study fails primary endpoint in focal seizures

Praxis Precision Medicines, Inc. June 1, 2026, 4:28 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

PLUR

Pluri gets EIB nod for loan talks; no enforcement until July 3 on €20M maturing today

Pluri Inc. June 1, 2026, 4:06 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

FULC

Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review

Fulcrum Therapeutics, Inc. June 1, 2026, 4:05 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-032854

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.